Tin tức & Cập nhật

Triple combination asthma inhaler works in patients with persistent airflow limitation
Triple combination asthma inhaler works in patients with persistent airflow limitation
17 Mar 2023

A novel once-a-day inhaler for asthma that contains a fixed-dose combination of the corticosteroid mometasone furoate (MF), the long-acting beta-agonist indacaterol acetate (IND), and the long-acting muscarinic antagonist glycopyrronium bromide (GLY) appears to have a favourable effect in patients with persistent airflow limitation (PAL), according to a post hoc analysis of the IRIDIUM study.

Triple combination asthma inhaler works in patients with persistent airflow limitation
17 Mar 2023
Pituitary-targeting seliciclib shows promise in treatment of Cushing disease
Pituitary-targeting seliciclib shows promise in treatment of Cushing disease
15 Mar 2023